PCM
IMA

Prelude Capital Management’s ImageneBio Inc IMA Stock Holding History

Prelude Capital Management’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,990
Closed -$65K – 1376
2026
Q1 		$65K Sell
12,990
-505
-4% -$3.28K 0.01% 1104
2025
Q4 		$93.1K Buy
+13,495
New +$100K 0.01% 1197
2024
Q4 		– Sell
-4,220
Closed -$87.6K – 1360
2024
Q3 		$87.6K Buy
+4,220
New +$85.3K 0.01% 1165

Other funds holding IMA

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return

Prelude Capital Management's IMA Position: Q2 2026 in Review

Prelude Capital Management sold out of ImageneBio Inc (IMA) in Q2 2026, closing a stake of 12,990 shares — an estimated $65K sold.

Prelude Capital Management first reported a position in IMA in Q3 2024 and held it in 3 quarters. The position peaked at $93.1K in Q4 2025. 35 funds tracked by Wall St. Rank hold IMA as of Q2 2026.

  • Prelude Capital Management reported no remaining ImageneBio Inc position as of Q2 2026 after selling out during the quarter.
  • Prelude Capital Management sold 12,990 ImageneBio Inc shares in Q2 2026, an estimated $65K.
  • Prelude Capital Management first reported a position in ImageneBio Inc in Q3 2024 and held it in 3 quarters.
  • Prelude Capital Management's ImageneBio Inc position peaked at $93.1K in Q4 2025.
  • 35 funds tracked by Wall St. Rank held ImageneBio Inc as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.